This area of our website is for healthcare professionals only

Please click below to declare your professional status:

YES, I am a healthcare professional  NO, I am not a healthcare professional

NHSE&I is working with Novartis Pharmaceuticals UK Ltd as part of a collaboration which includes resources in the form of funding, skills, expertise, project management and administrative support. Cholesterol Now is part of this collaboration for which Novartis has provided funding. HEART UK have contributed expertise in the development of the materials and hosted this initiative on their website, AAC have contributed to the development of the strategy, campaign and materials. Both the AAC and Novartis have checked these materials for factual accuracy and against the relevant guidance or codes, as applicable.

Cholesterol Now is a campaign to give healthcare professionals tools and information on cholesterol management to support patients in taking control of their cardiovascular health

Cardiovascular disease (CVD) remains the leading cause of premature mortality in England, causing a quarter of all deaths in the UK (1). Improving the treatment of high-risk conditions, such as high cholesterol, is a vital part of CVD prevention. As set out in the NHS Long Term Plan - CVD is the single biggest area where the NHS can save lives over the next 10 years

High cholesterol is a risk to health and well-being

  • About 220,000 people in the UK have familial hypercholesterolaemia (FH), of whom less than 8% are currently identified (2)
  • 7.1% of deaths in England are caused each year by high cholesterol (3)
  • There are over 100,000 hospital admissions in the UK each year due to heart attacks – that’s 1 every 5 minutes (4)
  • Research has shown that a 1-mmol/L reduction in LDL-C reduced the risk of major cardiovascular events by 23% (5)


Conversations with patients about cholesterol management

Watch real clinicians guide patients through common cholesterol-related scenarios, then click the link to find out more by exploring our e-learning modules

Reducing CVD risk through lifestyle changes

Reducing CVD risk through lifestyle changes Sharon, 60, is meeting with a dietitian after a referral from her GP.

See how lifestyle changes can influence cardiovascular health and  overall well-being

For more information on diet and lifestyle, visit the HEART UK e-learning modules


Addressing statin intolerance

Lynda, 80, is experiencing muscle pain and is concerned it's caused by her statin. Explore how the GP helps relieve this symptom while keeping Lynda’s cholesterol under control.

For more information on statin intolerance, visit the HEART UK e-learning modules


Identifying FH

Paul, 45, is concerned about the risk of heart attack in his family. Watch how the GP discusses this with Paul and makes a recommendation of FH and cholesterol testing

For more information on FH, visit the HEART UK e-learning modules


Cholesterol management guides for patients

Discover free educational guides for patients that you can download and share

By clicking the link below you will be leaving the Cholesterol Now page. The content has not been checked against applicable codes.

Get free learning tools


Tackling Cholesterol Together

Explore these initiatives from HEART UK, the Accelerated Access Collaborative (AAC) and the AHSN Network

By clicking the links below you will be leaving the Cholesterol Now page. The content has not been checked against applicable codes.

AAC, Accelerated Access Collaborative; AHSN, Academic Health Science Networks; CVD, cardiovascular disease; FH, familial hypercholesterolaemia; NHSE&I, NHS England and NHS Improvement


1. National Health Service (NHS). The NHS Long Term Plan. Available at: (Accessed October 2021).

2. National Health Service (NHS). Familial Hypercholesterolaemia (FH). Available at: (Accessed October 2021).

3. GOV. Health matters: preventing cardiovascular disease. Available at: (Accessed October 2021).

4. British Heart Foundation (BHF). Facts and figures. Available at: (Accessed October 2021).

5. Silverman M et al. JAMA 2016; doi:10.1001/jama.2016.13985.